Literature DB >> 21437046

The impact of asthma on the gastrointestinal tract (GIT).

Warren Antonio Vieira1, Etheresia Pretorius.   

Abstract

The gastrointestinal tract (GIT) of vertebrates is composed of several distinct compartments and glands as well as an extensive mucosal surface. Its primary function is that of chemical and physical digestion of food and the absorption of nutrients; however, due to its continual antigen exposure, the GIT also has an important defensive immunological function. The GIT's immunological participation is facilitated by the mucosa-associated lymphoid tissues, thought to share the mucosal immunological system with the respiratory mucosa-associated lymphoid tissues. As a result of this shared mucosal immunity, it has been hypothesized that bronchial asthma may be able to affect the body's GIT in the same pathophysiological manner as the airways and lungs. Here we discuss the link between bronchial asthma and pathophysiological features in the GIT - including leukocyte influx, goblet cell alterations, fibrosis, and epithelial and villous atrophy.

Entities:  

Keywords:  asthma; common mucosal system; fundus; gastrointestinal tract; pylorus

Year:  2010        PMID: 21437046      PMCID: PMC3047918          DOI: 10.2147/JAA.S10592

Source DB:  PubMed          Journal:  J Asthma Allergy        ISSN: 1178-6965


Within the vertebrate body the gastrointestinal tract (GIT) plays numerous vital roles, including the digestion of food, the absorption of nutrients and water, and the formation of feces for elimination.1,2 Another essential role of the intestines is immune defense due to continual exposure to various antigens, both harmless and pathogenic, from the vertebrate’s consumed food and resident, commensal organisms. Its immunological participation is facilitated by the GIT’s mucosa-associated lymphoid tissues.3–5 This tissue is thought to be connected to the respiratory system, as will be explained below, by means of the mucosal immunological system. The examination of the GIT amongst asthmatics has shown various pathological alterations, some of which correlate to that seen in the respiratory system, under similar conditions, and may have arisen due to bronchial asthma using the mucosal immunological system as a means of affecting this region of the body. In this review we will assess the connection that may allow for this process to arise, as well as the documented alterations identified within the GIT of asthmatics. This review was construed based upon articles and reviews found through Medline, PubMed, Science Direct, and Scopus using various search terms including asthma, GIT, GALT, stomach, intestines, and pathophysiological effects.

The common mucosal system

The gut associated lymphoid tissue (GALT) is the specialized barrier with which the mucosal immune system is associated within the GIT.2,4 The lymphoid tissue of this organ is present in the GIT as diffuse lymphocytic infiltrate or large nonencapsulated aggregations, such as Peyer’s patches.2 It is exposed continually to antigens, which it must determine the nature of – either harmless (such as food and commensal organisms) or dangerous (pathogens) – so as to protect the body from the external environment.4,5 The mucosa-associated lymphoid tissues are resident not only in the GIT but also within the respiratory tissues. Both the respiratory tissues and GIT-associated mucosal surfaces have numerous common morphological and functional characteristics, with the mucosal immunological system believed to be one such common feature.3 The mucosal immune system comprises of three lines of defense: The non-specific first line defense system – that is the epithelium cells which essentially act as a sieve with the aim of preventing foreign, unwanted antigens from penetrating the mucosa.4 The innate defense system – that being composed of natural killer cells, macrophages, and epithelial cells.4 The adaptive immune defense system – composed of the lamina propria, lymphocytes, and Peyer’s patches.4 Animal experiments have proven that selective trafficking of lymphocytes occurs between these two mucosal surfaces, with migration being facilitated through the lymphatic and circulatory systems that connect the body’s various glandular and mucosal sites.5 Although this process has been demonstrated within numerous animal studies, little data exist to support its occurrence in humans. Human B and T lymphocytes, macrophages, and mast cells do appear to communicate between lymphoid populations of mucosal tissues; for example, activated lymphocytes have been shown to circulate between the mucosal tissues of the lungs, salivary glands, and GIT in human asthmatics.3,5,6 It is subsequently hypothesized that this connection in mucosal immunity of the body causes bronchial asthma to affect the entire body’s mucosal system, in turn giving rise to the same pathophysiological features associated with asthma in the respiratory tissues in the GIT.5,6 Hypoxemia, hypercapnia development, microcirculatory alterations, and endocrine impairment within the GIT are some of the pathophysiological features that have been reported amongst suffers of the disease, helping to validate this hypothesis.7 Scientific literature, in terms of this topic, constitutes only a few studies but appears to support the hypothesis that a link exists between bronchial asthma and the GIT. Further research on this topic would greatly help to validate and to understand the already existing, although limited, knowledge available. The two compartments of the GIT which have been examined within the literature under asthmatic conditions, are the stomach, which holds acidic gastric contents and facilitates a churning action to reduce the ingested bolus to acidic chyme, and the small intestine, the essential absorption and digestive unit of the GIT. The large intestine, participating in water absorption, final digestion, and the formation of feces, does not appear to have been assessed under asthmatic conditions within literature.1,2 Table 1 summarizes the overlapping pathological features described in scientific literature between the body’s lungs and airways, stomach, and small intestines, which will be discussed in detail below.
Table 1

The overlapping pathological features, ascribed to asthma, within different regions of the body, namely the lungs and airways, the small intestine, and the stomach, of humans

Phenomena ascribed to asthmaLungs and airwaysSmall intestineStomach
Cellular atrophySurface epitheliumSurface, pit, crypt, and glandular epitheliumSurface, pit, crypt, and glandular epithelium
Fibrosis?
Increased cellular factor presenceNumerous pro-inflammatory factors including IL5/13IL-5/13 and CMCSF?
Increased leukocyte infiltrationEosinophils, lymphocytes, mast cells, monocytes/macrophages, and neutrophilsEosinophils, lymphocytes, and mast cellsLymphocytes
Mucus composition alterationsGoblet cells?Fundic surface epithelium
Thought to be a T-cell mediated disease?

Note: ☑ = present, ? = unknown.

The effects of asthma on the stomach

The stomach of asthmatics has been observed as undergoing various structural and histological alterations.

Cellular atrophy

When undiluted, the stomachs mucosa and submucosa are present in a state of prominent longitudinal folds – rugae. These folds allow the stomach the ability to distend and smooth out upon food acquisition, although the stomach’s surface still retains an irregular appearance due to the surfaces subdivision by grooves – gastric areas.1,2,8,9 These gastric areas possess pits or floveolae, in to which three to seven gastric glands open.8 The cardia, situated at the entrance of the stomach from the esophagus, and pylorus, the terminal funnel-shaped region of the stomach, have similar histology in term of their gastric glands. Both are rich in simple or branched tubular mucosa mucus-secreting glands, which open into the floveolae.2,8,10 The mucosa of the fundus and corpus possess straight, tubular gastric glands, although they may also possess basal branching glands.2,9 Simple columnar epithelial cells, each with basal oval nuclei and mucin droplets, cover the luminal surface of the stomach.9 They participate in protecting the stomach from self-digestion from the stomach’s own proteolytic and acidic secretions.2,8 A light microscopic study has revealed that the stomach undergoes degeneration processes as well as surface, pit, crypt, and glandular epithelium atrophy.7 Erosive lesions have been reported in the stomach’s mucosa, found in conjunction with parietal cell hyperplasia and hyperfunctioning; parietal cells being responsible for the stomachs hydrochloric acid production and secretion.2,7–9 It is believed that the lesions arise as a result of a gastrin-induced event whereby the stomach’s parietal cells are overstimulated though an overproduction of histamine by ECL and mast cells.7

Hemodynamic alterations

The lamina propria and submucosa of the stomach are rich in blood vessels which provide the necessary metabolites as well as waste-product, absorbed nutrient, and metabolite removal services. They also provide the stomach with the necessary regulating factors, for the regulation of the mucosal glands secretary activities.1,2,8,9 The bronchial blood vessels of asthmatics undergo numerous alterations, including angiogenesis, hypertrophy, and vasodilation.11–13 Numerous vasoactive biomolecules have been identified as possible candidates for these hemodynamic alterations within the respiratory tissues of asthmatics, including histamine, interleukin-8 (IL-8), and, of particular importance in facilitating angiogenesis, vascular endothelial growth factor (VEGF).11,14,15 Hemodynamic alterations, primarily within in the gastric folds where the endothelium reveals a heterogeneous structure, have been reported amongst asthmatics.7 Further research is required to determine whether or not these stomach hemodynamic alterations are facilitated by the same vasoactive biomolecules as in the respiratory systems of asthmatics.

Leukocyte influx

Due to the stomach’s continual exposure to antigens, it plays an essential role in the body’s immune defense. The GALT of the stomach, like that of the rest of the GIT, is essential in preventing harmful antigen uptake while still allowing the absorption of nutrient molecules.16 The GALT of the stomach is composed of numerous parts including diffuse lymphatic tissues, intraepithelial lymphocytes, epithelium, and eosinophils. Lymphatic nodules have been identified in human and animal tonsils, ileum, and appendix but their presence in the stomach has not been studied in-depth.17 The cardiac glandular region of the Bactrian camel’s stomach has been reported to hold lymphatic nodules, while Eroschenko (2005) has documented the occasional presence of human fundic and pyloric lamina propria sub-glandular lymphoid nodules.17 All the lymphoid elements, responsible for controlling immune responses, are composed of T and B lymphocytes. Eosinophils, due their prominent recruitment to the body’s GIT under control conditions, are a common infiltrating leukocyte of the stomach.18,19 A defining histopathological feature of the respiratory tissues amongst asthmatics is the increased infiltration of leukocytes, predominantly eosinophils and allergen-specific clusters of differentiation (CD) 4+ T helper (Th) 2 cells.4,13,14,20–24 The entire stomach’s mucosa, as in the respiratory tissues, during asthma has been noted to show an increased influx of lymphocytes; however, no researchers to date have determined if these invading lymphocytes are allergen-specific CD4+ Th2 cells.7 As enhanced leukocyte infiltration into a vascularized tissue is a common feature of inflammation, the stomach of asthmatics may be in a state of inflammation.20,25

Mucus production alterations

Goblet cell hyperplasia and increased mucus production is commonly described within the airways of asthmatics along with an alteration in the composition of the released mucus.12,26,27 Under asthmatic conditions, mucin protein expression appears to be altered, with the mucus itself being found to be more adhesive and less fluid in nature.12–14,27,28 The fundal surface epithelium mucin granules have been seen to possess a polymorphic nature based upon the severity of the individual’s asthma. Severe to moderate asthmatics possess mucin granules with an electron transparent nature when viewed under a TEM while mild to moderate asthmatics’ mucin granules possess a osmophilic nature.7 Moderate to severe asthmatics hold a large number of mixt-cells, in possession of a large number of mucin granules, within their fundal glands. The occurrence of these mixt-cells may either be the result of delayed glandular differentiation or the inhibition of protein synthesis due to stomach degeneration and emergency compensation through increased mucus production.7 In the pylorus, on the other hand, surface epithelium cells possess round, electron dense granules and, within moderate asthmatics, hyperplasia of its endocrine cells.7

The effects of asthma on the small intestine

The entire small intestinal mucosa of asthmatic humans has been shown to undergo architectural abnormalities and cytokine production alterations similar to those in the bronchial mucosa during asthma as well as being reminiscent of the pathology associated with gluten-sensitive enteropathy (GSE).5

Blood vessel alterations

The lamina propria and submucosa of the small intestine, as in the stomach, are rich in blood vessels which provide the necessary metabolites as well as waste products and absorbed nutrients, such as amino acids and monosaccharides derived from protein and carbohydrate catabolism, respectively, at this absorption site, removal services.1,2,8,9,29 They also supply agents which help to regulate the small intestine’s digestive functions.1,2,8,9 Bronchial blood vessels of asthmatics undergo numerous alterations, including angiogenesis, hypertrophy, and vasodilation.11–13 Numerous vasoactive biomolecules have been identified as possible candidates for these hemodynamic alterations within the respiratory tissues of asthmatics, including histamine, IL-8, and, of particular importance, VEGF.11,14,15 The villi’s microcirculatory beds present an endothelium of a heterogeneous nature under asthmatic conditions.7 Further research is required to determine whether or not these intestinal hemodynamic alterations are facilitated by the same vasoactive biomolecules as in the respiratory systems of asthmatics.

Cytokine alterations

IL-5 and IL-13 are found at increased levels within the mucosa of asthmatic airways compared to those of nonasthmatics.30,31 An increase in the mucosa’s IL-13, IL-5, and cellular macrophage colony stimulating factor (CMCSF) content has also been identified in the GIT’s lamina proprias eosinophil granules and mast cells cytoplasmic granules.5 Whether these eosinophils and mast cells are derived from the asthmatic respiratory system, via the common mucosal immune system, or arise in the small intestine itself, due to the surrounding possibly inflammatory stimuli, is unknown. Interestingly, the lymphocytes of the GIT are unable to express these cytokines, although the bronchi can. It is speculated that this difference between the GIT and bronchi lymphocytes may be due to exposure to different cytokine microenvironments at these two distinct mucosal sites, resulting in different cytokine expression by the lymphocytes.5 The role of IL-13, IL-5, and CMCSF in the intestine during asthma is unknown; however, they are involved in eosinophil survival, proliferation, and function as well as in modulating the body’s immune responses at mucosal sites.5

Fibrosis in the lungs and GIT

Fibrosis can be defined as an incorrectly regulated wound healing process, commonly facilitated by chronic inflammation as a result of repeated injury and repair processes occurring.32 Myofibroblasts are the most important cellular participants in this, traditionally considered, CD4+ Th2 cell cytokine system. The importance of these fibroblastic cells, located within the body’s granulation tissues, is related to that fact that they are able to produce and control a majority of the factors and functions specific to the disease.32 Fibrosis via the accumulation of sub-epithelial myofibroblasts is a prominent feature of asthmatic airway remodeling.12,14 This process can affect the structure of the airways through the secretions of various growth factors, inflammatory molecules and ECM elements by the myofibroblasts themselves.12 Moderate diffuse fibrosis may be present within the small intestine of asthmatics.7 Its presence is understandable in the GIT as fibrosis commonly occurs in response to inflammation, which would appear to be present in the GIT of asthmatics due the feature of increased leukocyte influx, and may even contribute to furthering this inflammatory state.32,33

Leukocyte infiltration

The body’s small intestine is exposed to an array of bacteria, bacterial products, and dietary antigens, which all necessitate the need for correct and efficient immune responses for homeostasis to be maintained.34–36 This is achieved through the GALT, with the mucosa of the GIT itself possessing the largest and most complex portion of the body’s immune system, with about 75% of all the body’s immune cells being localized to the GIT.35–37 The small intestine’s GALT possesses lymphoid elements in the form of Peyer’s Patches, mesenteric lymph nodes (MLN), and isolated lymphoid follicles.18,35,38 These lymphoid elements are composed of T and B lymphocytes; with the intestinal T cell populations being important participants in the mucosal barrier through their sensing of invading bacteria and their secreting of cytokines for the regulation of other infiltrating immune cells.18 The effecter cells, regulated by the intestinal lymphocytes, are situated in the mucosa too and comprise lymphocytes, dendritic cells, macrophages, neutrophils, granulocytes, and mast cells.18,34 Intestinal macrophages constitute about 10%–20% of all the mononuclear cells in the intestinal lamina propria as well as being the largest collection of macrophages in the body.36 They are continually recruited from blood monocytes and show a larger population size within the small intestine in comparison to the large intestine.35,36 Tissue macrophages are known to be essential in maintaining homeostasis by participating in the removal of altered cells, tissue remodeling, repair, and inflammation. The intestinal macrophages, though, are unlike other tissue macrophages, showing only minimal inflammation capabilities and are incapable of acting as professional antigen presenting cells.36 It is believed that this nature of intestinal macrophages is the result of their co-evolution with their host’s intestinal flora so as to diminish continual stimulation of inflammation and thus maintain local tissue homeostasis. They have low, or even absent, expression of surface CD48, CD8, and CD86; low levels of proinflammatory cytokine production and are relatively unreceptive to proinflammatory stimuli, for example they do not respond to lipopolysaccharide.35,36 They do, however, still act as powerful phagocytic cells, showing potent bactericidal activates.36 Under control conditions most of the body’s eosinophils are recruited into the GIT’s lamina propria, excluding the esophagus. Their levels occur independently of lymphocyte and enteric flora levels, indicating a unique regulation system for their recruitment in comparison to other leukocytes. This regulation is achieved by the continual expression of eoxatin-1 by the GIT, which recruits this leukocyte.19 During asthma the bronchial epithelium and lamina propria show infiltration of lymphocytes and eosinophils, and this feature has also been found in the small intestine of asthmatics. Additionally, the intestinal lamina propria has shown increased mast cell infiltration.5,7 This infiltration of lymphocytes and mononuclear cells into the lamina propria does not differ between allergic and non-allergic asthmatics although treatment has been seen to induce an effect. Those utilizing oral steroids, when suffering from severe asthma, show significantly lower mast cell and lymphocyte counts than those who utilize inhaled steroids, when suffering from moderate asthma, and those who remain untreated, due to suffering from only mild asthma.5 These features would appear to indicate that the small intestine of asthmatics is likely to be in a state of inflammation.20,25 Mucosal lesions are seen in GSE, which are mediated by the action of T cells. As bronchial asthma is considered to be a T cell-mediated disease, it has been hypothesized that the lesions present in the small intestine of asthmatics are facilitated by a similar mechanism to that occurring in GSE.5

GIT permeability

Benard et al (1996) revealed, through the utilization of the Chromium ethyleneddiaminetetraacetic acid (CrEDTA) test, that the small intestine of asthmatics showed increased permeability in comparison to that of control patients. The permeability did not differ between allergic and non allergic asthmatics, severity of the disease, or the steroid treatments utilized.6 The CrEDTA test is a highly sensitive but low specificity test. This test unfortunately did not reveal the location of the small intestine’s permeability, although the involvement of the small intestine’s tight junctions has been proposed.6 The mechanism for this increased permeability in asthmatics is unknown; it is unlikely that this feature is a result of the common mucosal system as it has not be found to correlate with factors of airway asthma, such as disease severity and treatment utilization.6

Goblet cell alterations

Amongst the resident epithelium cells population of the small intestines mucosa, there exists a group of specialized cells known as goblet cells. These cells, although at much lower concentrations than their simple columnar counter parts, provide each villi of the small intestine with a peppered appearance.2,8,9 These cells are responsible for the small intestine’s mucus production, which protects and lubricates the luminal walls.1,9 A characteristic of allergic inflammation seen in the small intestine in Ozdemir et al’s 2007 study was that ovalbumin (OVA) sensitized mice showed increased mucus production, facilitated by the mucosa’s goblets cells. The goblets cells were noted to increase both in number and size. The mean goblet size in the duodenum was found to roughly double, while that in the jejunum and ileum increased roughly 3-fold.39 Goblet cell hyperplasia and increased mucus production is commonly described within the airways of asthmatics.26 The presence of goblet cell hyperplasia in mild and moderate asthmatics has been attributed with roughly a 3-fold increase in goblet cell number and stored mucus volume in comparison to controls and hence is comparable to that seen in the small intestines of the sensitized mice studied by Ozdemir et al.27,39,40 Unfortunately, although comparable, a clear relationship between intestinal goblet cell hyperplasia and hyperfunctioning could not be extrapolated as Ozdemir and coworkers only considered the one-way effect of a food allergen presented intragastricularly that subsequently induced asthma. Whether the process works in the reverse, so that asthma alone induces the same responses in the small intestines goblets cells, was not examined.39

Villous atrophy

The entire small intestine possesses permanent parallel folds, referred to as plica circularis, which are formed by the mucosa and part of the submucosa. Upon each of these folds lie extensions known as villi, constituted by the lamina propria and epithelium of the mucosa.1,2,8,9 Upon the mucosa of these extensions lie a large population of simple columnar epithelium cells in the possession of microvilli upon their luminal surfaces.1,2,8,9 The plica circularis, villi, and microvilli all contribute to a larger surface area through which nutrient, water, and electrolyte absorption can take place.1,2,8,9 In an experimental study with mice given OVA intra-gastrically and intraperitoneally a significant decrease was found in their villous/crypt ratio – villous atrophy – due to a reduction in villi height as well as an increase in crypt depth.39,41 Mice sensitized with OVA only intraperitoneally showed an increase in their villous/crypt ratio, although this process was also suggested to be a proinflammatory response of the mucosa to the antigen.39 The mice sensitized by OVA both intragastrically and intraperitoneally, with a predisposition to the antigen, developed allergic airway responses as well. The antigen therefore appears to be taken up by the GIT and presented preferentially to naïve T lymphocytes in the Peyer’s Patches of the small intestine. The T cells would then be primed and subsequently enter the blood stream to travel to other immune mucosal sites, such as that of the respiratory system, or they would remain in the GIT.39 However, whether the induction of asthma subsequently facilitate villous atrophy was not assessed. One cannot assume from these results that the induction of asthma first would induce villous atrophy, as the process of villous atrophy may only be a unidirectional event requiring solely gastrointestinal antigen exposure rather than the induction of asthma. Although partial villous atrophy is seen amongst human asthmatics as well as surface, pit, crypt, and glandular epithelium atrophy in the duodenum, it was not stated or even considered if their asthma arose from gastrointestinal antigen exposure(s), as was the case for the mice studied by Ozdemir and coworkers, which creates suspicion as to whether or not the perceived atrophy was a result of intragastricular food allergen exposure.5,7

Clinical relevance

The full clinical relevance of asthma’s GIT impact has not been examined within the literature to date. The most likely consequence for asthmatic patients would be impaired digestive and absorption functions as well increased risk of disease contraction. The cellular atrophy noted within the GIT would be a likely means for reduced nutrient digestion and absorption. The undigested and unabsorbed nutrients and electrolytes in the intestines could further more osmotically withdraw fluids from of the intestines inducing diarrhea.42–45 A further implication of cellular atrophy would be the formation of GIT ulcerations. Increased mucosal permeability described by Benard and coworkers in 1996 would entail increased bacterial and bacterial product uptake. This would subsequently trigger further immune activation and inflammation within the GIT and possibly induce various related diseases.6,44–48

Conclusion

It can be concluded from the above review of literature, that studies conducted so far appear to support the hypothesis that a link exists between bronchial asthma and the GIT, particularly when considering features such as increased leukocyte infiltration, goblet cell alterations, fibrosis, and cytokine alterations, which are characteristic of asthmatic airways and lung tissues. Unfortunately, our understanding of this asthma-GIT relationship is still limited. Further research is required in order to completely validate the suggested hypothesis and make sure that the perceived results are not the result of ingested food allergens, as may have been the case in the study by Ozdemir and coworkers.
  40 in total

Review 1.  HIV infection and the gastrointestinal tract.

Authors:  Donald P Kotler
Journal:  AIDS       Date:  2005-01-28       Impact factor: 4.177

Review 2.  Adaptations of intestinal macrophages to an antigen-rich environment.

Authors:  Mirjam Schenk; Christoph Mueller
Journal:  Semin Immunol       Date:  2006-10-18       Impact factor: 11.130

Review 3.  Modulating leukocyte recruitment in inflammation.

Authors:  Margaret Kelly; John M Hwang; Paul Kubes
Journal:  J Allergy Clin Immunol       Date:  2007-06-07       Impact factor: 10.793

Review 4.  Asthma history and presentation.

Authors:  Bruce R Gordon
Journal:  Otolaryngol Clin North Am       Date:  2008-04       Impact factor: 3.346

Review 5.  Eosinophils: biological properties and role in health and disease.

Authors:  Simon P Hogan; Helene F Rosenberg; Redwan Moqbel; Simon Phipps; Paul S Foster; Paige Lacy; A Barry Kay; Marc E Rothenberg
Journal:  Clin Exp Allergy       Date:  2008-04-01       Impact factor: 5.018

Review 6.  Goblet cell and mucin gene abnormalities in asthma.

Authors:  John V Fahy
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

Review 7.  Leucocytes in asthma.

Authors:  A B Kay
Journal:  Immunol Invest       Date:  1988 Nov-Dec       Impact factor: 3.657

Review 8.  Chronic diarrhea and AIDS: insights into studies with non-human primates.

Authors:  Karol Sestak
Journal:  Curr HIV Res       Date:  2005-07       Impact factor: 1.581

9.  Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.

Authors:  B Wallaert; P Desreumaux; M C Copin; I Tillie; A Benard; J F Colombel; B Gosselin; A B Tonnel; A Janin
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

10.  Observations on aggregated lymphoid nodules in the cardiac glandular areas of the Bactrian camel (Camelus bactrianus).

Authors:  Wen-Hui Wang
Journal:  Vet J       Date:  2003-09       Impact factor: 2.688

View more
  10 in total

Review 1.  Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation.

Authors:  Zhihan Wang; Qinqin Pu; Canhua Huang; Min Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Antibiotic perturbation of gut bacteria does not significantly alter host responses to ocular disease in a songbird species.

Authors:  Chava L Weitzman; Lisa K Belden; Meghan May; Marissa M Langager; Rami A Dalloul; Dana M Hawley
Journal:  PeerJ       Date:  2022-06-10       Impact factor: 3.061

Review 3.  Emerging pathogenic links between microbiota and the gut-lung axis.

Authors:  Kurtis F Budden; Shaan L Gellatly; David L A Wood; Matthew A Cooper; Mark Morrison; Philip Hugenholtz; Philip M Hansbro
Journal:  Nat Rev Microbiol       Date:  2016-10-03       Impact factor: 60.633

4.  Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model.

Authors:  Kim A T Verheijden; Linette E M Willemsen; Saskia Braber; Thea Leusink-Muis; Dianne J M Delsing; Johan Garssen; Aletta D Kraneveld; Gert Folkerts
Journal:  Respir Res       Date:  2015-02-07

5.  The development of allergic inflammation in a murine house dust mite asthma model is suppressed by synbiotic mixtures of non-digestible oligosaccharides and Bifidobacterium breve M-16V.

Authors:  K A T Verheijden; L E M Willemsen; S Braber; T Leusink-Muis; P V Jeurink; J Garssen; A D Kraneveld; G Folkerts
Journal:  Eur J Nutr       Date:  2015-05-24       Impact factor: 5.614

Review 6.  The unrecognized occupational relevance of the interaction between engineered nanomaterials and the gastro-intestinal tract: a consensus paper from a multidisciplinary working group.

Authors:  Antonio Pietroiusti; Enrico Bergamaschi; Marcello Campagna; Luisa Campagnolo; Giuseppe De Palma; Sergio Iavicoli; Veruscka Leso; Andrea Magrini; Michele Miragoli; Paola Pedata; Leonardo Palombi; Ivo Iavicoli
Journal:  Part Fibre Toxicol       Date:  2017-11-25       Impact factor: 9.400

7.  Incidence and economic burden of community-acquired gastroenteritis in the Netherlands: Does having children in the household make a difference?

Authors:  Roan Pijnacker; Marie-Josée J Mangen; Gerrita van den Bunt; Eelco Franz; Wilfrid van Pelt; Lapo Mughini-Gras
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

8.  The Combination Therapy of Dietary Galacto-Oligosaccharides With Budesonide Reduces Pulmonary Th2 Driving Mediators and Mast Cell Degranulation in a Murine Model of House Dust Mite Induced Asthma.

Authors:  Kim A T Verheijden; Saskia Braber; Thea Leusink-Muis; Prescilla V Jeurink; Suzan Thijssen; Aletta D Kraneveld; Johan Garssen; Gert Folkerts; Linette E M Willemsen
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

9.  Neonatal gut and respiratory microbiota: coordinated development through time and space.

Authors:  Alex Grier; Andrew McDavid; Bokai Wang; Xing Qiu; James Java; Sanjukta Bandyopadhyay; Hongmei Yang; Jeanne Holden-Wiltse; Haeja A Kessler; Ann L Gill; Heidie Huyck; Ann R Falsey; David J Topham; Kristin M Scheible; Mary T Caserta; Gloria S Pryhuber; Steven R Gill
Journal:  Microbiome       Date:  2018-10-26       Impact factor: 14.650

Review 10.  The Gut Microbiota and Respiratory Diseases: New Evidence.

Authors:  Li Chunxi; Liu Haiyue; Lin Yanxia; Pan Jianbing; Su Jin
Journal:  J Immunol Res       Date:  2020-07-31       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.